Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Advances in ovarian cancer treatment beyond PARP inhibitors
Ovarian cancer has become the largest cause of gynaecological cancer-related mortality. It
is typically diagnosed at a late stage and has no effective screening strategy. Ovarian cancer …
is typically diagnosed at a late stage and has no effective screening strategy. Ovarian cancer …
[HTML][HTML] Exosomes in the diagnosis and treatment of renal cell cancer
Renal cell carcinoma (RCC) is the most prevalent type of kidney cancer originating from
renal tubular epithelial cells, with clear cell RCC comprising approximately 80% of cases …
renal tubular epithelial cells, with clear cell RCC comprising approximately 80% of cases …
[HTML][HTML] Non-epithelial ovarian cancers: how much do we really know?
A Cheung, S Shah, J Parker, P Soor, A Limbu… - International journal of …, 2022 - mdpi.com
Non-epithelial ovarian cancers (NEOC) are a group of uncommon malignancies that mainly
includes germ cell tumours (GCT), sex cord-stromal tumours (SCST), and some extremely …
includes germ cell tumours (GCT), sex cord-stromal tumours (SCST), and some extremely …
An overview of the role of MicroRNAs on carcinogenesis: a focus on cell cycle, angiogenesis and metastasis
L Pekarek, D Torres-Carranza… - International Journal of …, 2023 - mdpi.com
In recent years, the importance of epigenetic markers in the carcinogenesis of different
malignant neoplasms has been demonstrated, also demonstrating their utility for …
malignant neoplasms has been demonstrated, also demonstrating their utility for …
[HTML][HTML] Angiogenesis and anti-angiogenic treatment in prostate cancer: mechanisms of action and molecular targets
Prostate cancer (PC) is the most common cancer in men and the second leading cause of
cancer-related death worldwide. Many therapeutic advances over the last two decades have …
cancer-related death worldwide. Many therapeutic advances over the last two decades have …
Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls
We present the case of a patient with Lynch syndrome and metastatic colorectal carcinoma
(mCRC). The initial immunohistochemistry (IHC) test for deficient mismatch repair gave a …
(mCRC). The initial immunohistochemistry (IHC) test for deficient mismatch repair gave a …
Melanoma therapeutics: a literature review
PK Dhanyamraju, TN Patel - Journal of biomedical research, 2022 - pmc.ncbi.nlm.nih.gov
Melanoma is a relentless type of skin cancer which involves myriad signaling pathways
which regulate many cellular processes. This makes melanoma difficult to treat, especially …
which regulate many cellular processes. This makes melanoma difficult to treat, especially …
Potential prognostic biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) family members in breast cancer
Breast cancer remains the most common malignant cancer in women, with a staggering
incidence of two million cases annually worldwide; therefore, it is crucial to explore novel …
incidence of two million cases annually worldwide; therefore, it is crucial to explore novel …
Advances in adoptive T-cell therapy for metastatic melanoma
A Das, A Ghose, K Naicker, E Sanchez… - Current research in …, 2023 - Elsevier
Adoptive T cell therapy (ACT) is a fast develo**, niche area of immunotherapy (IO), which
is revolutionising the therapeutic landscape of solid tumour oncology, especially metastatic …
is revolutionising the therapeutic landscape of solid tumour oncology, especially metastatic …
[HTML][HTML] Hallmarks of the tumour microenvironment of gliomas and its interaction with emerging immunotherapy modalities
Gliomas are aggressive, primary central nervous system tumours arising from glial cells.
Glioblastomas are the most malignant. They are known for their poor prognosis or median …
Glioblastomas are the most malignant. They are known for their poor prognosis or median …